Stay updated on Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added, replacing the previous v3.5.3; this indicates an internal software or content-management update rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:35:20.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    <div>Updates the page’s revision/version label from <code>v3.5.2</code> to <code>v3.5.3</code>.</div>
    Difference
    0.1%
    Check dated 2026-04-24T06:28:26.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:56.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    No substantive changes detected in core content; study details, eligibility criteria, and outcome measures appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-26T12:14:51.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing v3.4.3; no study content or user functionality is affected.
    Difference
    0.1%
    Check dated 2026-03-19T08:26:48.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    - Revision tag updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:39:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.